Childhood cancer in Africa

Mariana Kruger1, Marc Hendricks, Alan Davidson

  • 1Department of Paediatrics and Child Health, Tygerberg Hospital, University of Stellenbosch, Cape Town, South Africa.

Pediatric Blood & Cancer
|November 12, 2013
PubMed

Insights

Most children with cancer in low- and middle-income countries (LMICs) lack treatment access. This paper reviews African childhood cancer care, highlighting successful programs and advocating for policy changes to improve access for all children.

Area of Science:

  • Pediatric Oncology
  • Global Health
  • Health Policy

Background:

  • The majority of pediatric cancer cases occur in low- and middle-income countries (LMICs).
  • Children in LMICs often face significant barriers to accessing essential cancer treatment.
  • Limited data exists on the current state of childhood cancer care across Africa.

Purpose of the Study:

  • To describe the current status of childhood cancer treatment in Africa.
  • To identify successful models for improving pediatric cancer care delivery.
  • To inform health-care policies for equitable cancer treatment access.

Main Methods:

  • Literature review of publications and dedicated websites.
  • Information collection through surveys.
  • Analysis of existing data on childhood cancer treatment in Africa.

Main Results:

  • Childhood cancer treatment in Africa is characterized by limited access and resources.
  • Successful initiatives include twinning programs (e.g., Malawi, Cameroon) and collaborative trials (e.g., Franco-African Childhood Cancer Group).
  • Significant disparities in care exist across the continent.

Conclusions:

  • Effective models for childhood cancer treatment exist and can be replicated.
  • Policy interventions are crucial to facilitate access to cancer care for all African children.
  • International collaboration and resource allocation are vital to address the childhood cancer crisis in Africa.

Related Concept Videos

What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
12.8K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.8K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Cancer Prevention02:59

Cancer Prevention

2.6K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.1K